Showing results (211-220 of 301) with videos related to

Sort By:
Pageof 31
Anticancer Research|July 14, 2015
Improvement of Impaired Immunological Status of Patients with Various Types of Advanced Cancers by Autologous Immune Cell TherapyTakashi Kamigaki, Hiroshi Ibe, Sachiko Okada, et al.
Virus Genes|October 1, 2013
Molecular evolution of the hemagglutinin and neuraminidase genes of pandemic (H1N1) 2009 influenza viruses in Sendai, Japan, during 2009-2011Irona Khandaker, Akira Suzuki, Taro Kamigaki, et al.
Anticancer Research|July 31, 2020
Adoptive Immune-Cell Therapy for the Treatment of Neuroendocrine Carcinoma of the Uterine CervixShigenori Goto, Yasuhisa Terao, Takashi Kamigaki, et al.
In Vivo (Athens, Greece)|December 28, 2018
Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter StudyJun Yamamura, Shunji Kamigaki, Masaki Tsujie, et al.
Oncology|February 17, 2005
Prevention of irinotecan-induced diarrhea by oral sodium bicarbonate and influence on pharmacokineticsTakao Tamura, Koichi Yasutake, Hogara Nishisaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[Successful chemoradiation therapy for local control of rectal cancer with multiple bone metastases--a case report]Tetsu Nakamura, Takashi Kamigaki, Shiro Takase, et al.
International Journal of Cancer|September 7, 2023
Effects of adoptive T-cell immunotherapy on immune cell profiles and prognosis of patients with unresectable or recurrent cholangiocarcinomaAkihiko Kida, Eishiro Mizukoshi, Masaaki Kitahara, et al.
Influenza and Other Respiratory Viruses|January 8, 2014
Estimating influenza outpatients' and inpatients' incidences from 2009 to 2011 in a tropical urban setting in the PhilippinesVeronica L Tallo, Taro Kamigaki, Alvin G Tan, et al.
BMC Infectious Diseases|March 31, 2022
Incidence of lower respiratory tract infection and associated viruses in a birth cohort in the PhilippinesKanako Otani, Mayuko Saito, Michiko Okamoto, et al.
Biological & Pharmaceutical Bulletin|July 5, 2006
MDR1 T-129C polymorphism can be predictive of differentiation, and thereby prognosis of colorectal adenocarcinomas in JapaneseTatsuya Koyama, Tsutomu Nakamura, Chiho Komoto, et al.
Pageof 31